HOLX - Hologic: Women's Health Play Looks Healthier Itself
2024-05-13 03:56:51 ET
Summary
- Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024.
- The company has a strong balance sheet, solid track record, and reasonable valuation, making it an attractive investment.
- Hologic recently made another bolt-on acquisition and expects organic sales to grow by 5-7%, leading to potential valuation expansion.
In February, I believed that shares of Hologic, Inc. ( HOLX ) were starting to look a bit more attractive as headwinds were disappearing. The women's health business benefited greatly from the pandemic (through its diagnostics business) yet the subsequent headwinds are ending in 2024....
Hologic: Women's Health Play Looks Healthier Itself